region are collected on-line with a small computer at repetition rates of 100 scans per second. Absorbance data at several wavelengths are processed by matrix equations phylline, acetaminophen, salicylamide, phenylbutazone, and secobarbital. We conclude that the computer-interfaced vidicon spectrometer is a viable tool for simultaneous multicomponent determinations.
AddItionalKeyphrases: drug assay #{149} computer-interfaced instrument #{149} analytical systems
Although ultraviolet spectrophotometry is used extensively for the determination of drugs in body fluids and other samples (1, 2), most current applications require that, before the measurement step, the drug of interest be separated from other drugs that absorb in the ultraviolet region. Because many samples contain multiple components, there are situations in which it would be advantageous to determine two or more components without a complete separation step. An early report by Sternberg demonstrated that absorbance data taken at several wavelengths can be used to compute the concentration of each of several species in mixtures of components which have overlapping spectra (3). Goldbaum (4) has tabulated ultraviolet data for several barbituates that suggest that it should be possible to differentiate quantitatively among different barbiturates in mixtures. All of the data reported to date have been based on applications of conventional scanning instruments that require several minutes for each complete scan of the spectrum, and as such offer only slight advantages over fast separation methods.
Recent reports from this laboratory have described applications of television camera (vidicon) tubes for rapid scanning spectroscopy (5-7). One report (7) described the application of the rapid scanning spectrometer for single-component drug determinations, and emphasized some of the unique capabilities of the system when used in conjunction with a small computer for on-line data acquisition and data processing. We have extended that study to include multicomponent drug mixtures based on absorbance measurements at several wavelengths for each mixture.
Drug mixtures reported here include an antiarrhythmic agent and its metabolite (procainamide and N-acetylprocainamide) in serum, two barbiturates (butabarbital and secobarbital), and seven common acidic drugs (phenobarbital, diphenylhydantoin, aminophylline, acetaminophen, salicylamide, phenylbutazone, and secobarbital). The first example illustrates the application of the concept to clinical samples while the other examples demonstrate the capabilities and limitations of the concept for very difficult problems. Drug concentrations ranged from 0 to 10 mg/liter for the antiarrhythmic agents, 2 to 24 mg/liter for the barbiturates, and 0 to 14 mg/liter for the acidic drugs. Slopes of least-squares fits of found versus added concentrations for several samples of each drug mixture averaged 1.003 ± .078. Intercept values averaged -0.15 ± 0.14 mg/liter. Standard estimates of the error averaged 0.58 mg/liter. These results indicate that the vidicon detector system used in this manner with a small computer for data processing represents a viable tool for simultaneous drug determinations.
Materials and Methods

Apparatus
The computer-interfaced rapid-scanning vidicon detection system has been described previously (5) (6) (7) and is not discussed here. 
Reagents
Phenobarbital
Procedure
Stock solutions of the drugs were prepared by dissolving a weighed amount of each drug in aqueous buffer at an appropriate pH. Standards and synthetic aqueous samples were prepared by serial dilution of these stock solutions. Serum samples were supplemented by adding the stock drug solutions with a microsyringe.
A 3-ml serum sample supplemented with the antiarrhythmic agents was processed by adding 0.5 g of NaCl and 0.2 ml of 5 mol/liter NaOH and extracting the drugs into 20 ml of chloroform. The chloroform was filtered and the drugs back-extracted into 6 ml of tartrate buffer (pH 3.5) for analysis.
Dark-current and 100% transmittance spectra were measured and stored on magnetic tape at the beginning of each set of experiments.
Then standards, synthetic aqueous samples, or serum extracts were placed in the sample cuvet one at a time and the spectra were measured and stored on magnetic tape. Absorbances for each sample at each analytical wavelength were then computed in the conventional manner. The rapid scanning feature (10 ms per scan) of the vidicon system permits several hundred spectra for each sample to be recorded and averaged in less time than is required for a single spectrum with conventional recording spectrophotometers.
This averaging process offers the opportunity for significant signal-to-noise improvement in absorbance data.
The computational procedure used in this work has been discussed previously by Sustek (9). Briefly, Beer's law is used in matrix form,
where A is a k-by-rn matrix of absorbances of m mixtures at k analytical wavelengths, K is a k-by-n matrix of absorptivities of n components at k analytical wavelengths, and C is an n-by-rn matrix of concentra- is evaluated by substituting absorbance data and known concentrations for standard mixtures into equation 1 and solving. (1) Once the absorptivity matrix has been determined, sample concentrations are calculated by
where C0 is a column matrix of the concentrations of each of the n components in the sample, A0 is a column matrix of sample absorbances at the k analytical
is an n by k matrix, and KT is the transpose of the K matrix.
Results
The wavelength scales are linear on all spectra reported below.
Procainamide and N-acetylprocainamide.
Procainamide (PA) is an antiarrhythmic agent and it is suspected that a metabolite, N-acetylprocainamide (NAPA), contributes to the therapeutic and toxic effects of PA (10). It is desirable therefore to determine the concentrations of both PA and NAPA simultaneously in serum of patients treated with PA. Figure 1 shows the ultraviolet absorption spectra for PA and NAPA in pH 6.0 buffer. The two spectra overlap significantly and do not shift noticeably with pH. For simultaneous determination of PA and NAPA, three standards were used for calibration at eight analytical wavelengths spaced around the absorption maxima of each compound, with 1024 spectra being averaged for all standards and samples. Figure 2A summarizes the results of simultaneous determinations of PA and NAPA in several synthetic aqueous samples. The number by each point on each plot identifies the sample to which it corresponds. A regression of calculated concentrations vs. added amounts gives a standard estimate of the error (11) for both PA and NAPA of about 0.1 mg/liter. This represents the precision of the method without complications from sample matrices. Figure 2B summarizes data for simultaneous determinations of PA and NAPA in sera supplemented with different amounts of the drugs and extracted as described above. Again, the number by each point identifies the sample to which it corresponds. The calculated values were corrected for a twofold dilution during extraction and for the extraction efficiencies, 74% for PA and 81% for NAPA. The regression of calculated versus added concentrations gave standard estimates of the error of about 0.4 mg/liter for PA and 0.3 mg/liter for NAPA. The increased scatter relative to aqueous samples is due to variabilities introduced by the extraction procedure. The intercepts of less than 0.1 mg/liter for both PA and NAPA indicate no significant interference.
Drugs
More complete regression data for Figures 2A and 2B are given in Table 1 .
These data demonstrate the potential capabilities of the approach to real samples for two components with moderately overlapped absorption spectra. We now Barbiturates. Figure 3A (top) represents the ultraviolet absorption spectra of butabarbital and secobarbital in 0.1 mol/liter NaOH and Figure 3B ferences between the spectra are small, they are real, with most difference being in the shape of the curve rather than in positions of maxima and minima. Because the spectrum of a mixture is quite similar to that of each of the components, this represents a rather severe test of the simultaneous method. Results are presented here for barbiturate mixtures to illustrate the capabilities of the method for very similar spectra.
In this example, eight spectra were averaged for each standard and each sample. For each barbiturate, seven standard solutions containing between 2 and 24 mg/liter of the barbiturate were used to evaluate absorptivities at each of 12 analytical wavelengths in the range from 235 to 275 nm. These absorptivities were then used to calculate the concentrations of butabarbital and secobarbital in each of seven synthetic aqueous samples. Figure 4 represents data for the seven samples based on absorbance data at each of 12 wavelengths for each sample. Numbers next to each point identify the dif- Thus, although the absorptivities have been determined with fair precision, the barbiturate data show increased scatter relative to PA and NAPA because of the close similarity of the barbiturate spectra. The dashed regression line for secobarbital includes all seven points and the solid line excludes the point at 2 mg/liter. Complete regression data for these samples are included in Table 1 .
Since these data demonstrate significant promise for this analytical concept for two component mixtures involving a high degree of overlap, it appeared desirable to evaluate the approach for other samples containing more components.
Results for a seven-component mixture are discussed in the next section. These drugs represent some common acidic drugs that can be detected in serum by using ultraviolet absorbance. Figure 5 includes the absorption spectrum for each of these drugs in pH 10 buffer. For a simultaneous determination of all seven drugs, 12 standards were used for calibration at 28 analytical wavelengths, with 2048 spectra being averaged for all standards and samples. Table 2 summarizes the results of determinations of all seven components in nine synthetic aqueous samples. The concentrations of the drugs in the samples have been determined to within 1 mg/liter in most cases. The exceptions involve mainly the barbiturates that have nearly identical spectra. For example, in sample eight, although 6 mg of phenobarbital per liter and no secobarbital was added, the calculations showed -0.7 mg of phenobarbital and 6.2 mg of secobarbital per liter. Also, in sample eight, 2.2 mg/liter was calculated for diphenylhydantoin while none was added. Careful study of the spectra in Figure 5 will show that a combination of secobarbital and diphenylhydantoin could produce a spectrum that is very similar to that of pure phenobarbital.
Although the sum of the two barbiturates is predicted reasonably well, it is not possible to distinguish between them in this complex situation, and it would be valid to report only total barbiturate.
Regression of calculated concentrations versus added amounts for all components in all samples gives a standard estimate of error of 1.4 mg/liter, while regression of all data except mixture 8 gives a standard error of 0.7 mg/liter. The regression statistics for all components in all samples are included in Table 1 .
Discussion
A fundamental assumption in the computational approach described above is that all absorbing components in the sample are accounted for in the absorptivity matrix. This means that any sample matrix, such as human serum, that has a variable background absorption spectrum from one sample to another will create serious problems for the method. Accordingly, the measurement method must be coupled with some separation method such as extraction or chromatography to isolate desired analytes from other absorbing species. The primary advantage of the proposed method is that it can simplify the separation step by eliminating the need for complete separation of all components. Data reported for procainamide
and N-acetylprocainamide demonstrate the effectiveness of the method for real samples after a suitable partial separation step. In addition to being somewhat simpler in execution than the two-step fluorometric procedure of Matusik and Gibson for these components (10), the present method reduces the need for an acidic pH, which can result in hydrolysis of NAPA.
Our data for the two-component barbiturate samples and for the seven-component acidic drug samples are intended to illustrate both potential strengths and weaknesses of the method. Stevenson (13) has described procedures for separating barbiturates into three groups and suggested determination of total barbiturate in each group. The data presented above indicate that it may be possible to quantitate individual drugs in these groups and therefore account for different potencies among the drugs. The data in Table 2 for up to sevencomponent mixtures illustrate two important points. The first is that subtle differences in the barbiturate (or other) spectra will be masked if the components are included with other components that give spectra that overlap the similar spectra. On the other hand, those data corresponding to samples that contain no barbiturates suggest that practical analyses of up to fivecomponent mixtures are feasible.
One of the most critical factors affecting the quality of results is the accuracy of the calibration step-in other words, the accuracy of the Q matrix. Each row of the matrix corresponds to a different component, and the computation of the concentration of a component depends only upon the row elements of the Q matrix corresponding to that component and the absorbance values. The elements of the Q matrix tend to be large for highly overlapping spectra such as the barbiturates and small for components with spectra well separated from the others such as salicylamide (see Figure 5 ). For example, the Q-matrix elements for phenobarbital, secobarbital, diphenylhydantoin, and salicylamide in the seven component mixture, discussed above were about ±200, ± 200, ±50, and ±5, respectively. Accordingly, small relative errors in either the Q matrices or in sample absorbance values produce larger absolute concentration errors for highly overlapping spectra than for well-separated spectra. For example, if we assume no error in the Q matrices for the four components mentioned above, and assume a constant absorbance error of +0.01, then the resulting concentration errors are -1.8 mg/liter for phenobarbital, +1.9 mg/liter for secobarbital (note the cumulative barbiturate error is near zero), +0.5 mg/liter for diphenylhydantoin, and only +0.1 mg/liter for salicylamide.
Although any sources of systematic or random error that affect either the Q matrix or the sample absorbance data will affect the results, the results are much more sensitive to errors during the calibration step that affect the Q matrices than to errors in sample absorbance measurement. Common sources of photometric error include photometric drifts, quantization error, stray energy, and wavelength errors (12). Of these, the wavelength reproducibility between standards and samples may be most critical, especially for overlapping spectra. We were careful in this work to ensure wavelength integrity between standards and samples and to limit total component concentrations to those that would not exceed the linear absorbance range imposed by the stray-energy component of the dispersion optics (7).
Because the value of the Q matrix tends to decrease as the number of wavelengths used in the analysis increases, it is desirable to use more wavelengths than there are components in the sample. Sustek has examined this problem in detail and recommends three to four times as many wavelengths as components in the sample (9). Because the relative errors in absorptivity will usually be smaller where the absorptivities are largest, analytical wavelengths near absorption maxima are generally best.
If one assumes a perfect Q matrix (no absorptivity errors), then the minimum variance in the computed concentration of a component can be estimated as the product of the variance in absorbance measurements times the main diagonal element of the (KTKY.l matrix for that component. Values of the matrix element for phenobarbital, diphenylhydantoin, and salicylamide in the seven-component mixture discussed above are 2.6 X 10, 3.0 X 10, and 4.8 X 10k, respectively. These data illustrate how the precision will be improved as the degree of overlap (see Figure 5 ) is reduced.
We conclude that the vidicon spectrometer coupled with a computer for matrix solution of simultaneous equations represents a viable detector system for a variety of separation methods, including liquid-liquid extraction and liquid chromatography.
This detection system can simplify the separation step by eliminating the need for complete separation of all components of interest.
